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Health chiefs in the Western Cape last
month confidently predicted that by the
end of next year there would be
treatment for every ART-eligible child in
the province younger than 14 years old.
Already an estimated 30% (or nearly
700 of an estimated 2 000) of all eligible
Western Cape children needing ART are
receiving it.
With the exception of Gauteng, this is
in stark contrast to the rest of the
country where several provincial sites
claiming readiness but lacking private
drug supplies continue to stare death in
the face daily.
The Western Cape's success is based
on timely, sustained and expanding
intervention, using a multidisciplinary
and coherent public/private task team
that meets weekly. Last year the
province reached a 100% roll-out of its
prevention of mother-to-child
transmission (PMTCT) programme,
thus dramatically reducing the number
of infected children being born.
The country's pioneering ART clinic,
run by Médecins sans Frontières (MSF)
in Khayelitsha outside Cape Town, last
month for the first time reported that
the demand for ARV treatment of
children was slowing down.
Dr Eric Goemaere, MSF's Head of
Mission in South Africa, said there was
a 'striking difference' between adults
and kids presenting in Khayelitsha.
‘We're flooded  with HIV-positive
adults (100 new treatment candidates
per month) who require urgent
treatment, but for the children it's going
much slower — the PMTCT is definitely
working’.
Goemaere said 96% of MSF-treated
mothers had chosen to exclusively
formula-feed  their infants, a factor he
believes contributed to their success.
By next year some 40 Western Cape
satellite sites are expected to revolve
around six central treatment hubs to
serve the region's estimated 2 000
children whose AIDS will then have
progressed to the stage where they can
be effectively treated.
At the time of writing, the province
had opened 16 ART treatment sites
catering for more than 2 000 HIV-
positive people. The government's
national treatment plan calls for six in
each province.
The province last year extracted R459
million (disbursed over 5 years) from
the Global AIDS, TB and Malaria Fund,
and early in March this year secured
another R30 million (disbursed over 3
years) from the UK-based NGO
'Absolute Return for Kids' to treat
parents. 
The province's initial PMTCT roll-out
has resulted in a reduction by more
than 22% in HIV transmission from
mother to child (which MSF now
estimates is down to 8.8%). In the USA
the mother-to-child transmission rate
stands at 1.1%.
Goemaere said the reduced
transmission figures were obtained
through (unpublished) MSF research
involving 500 mothers in the PMTCT
programme who were tested at 14
weeks using the accurate polymerase
chain reaction (PCR) method.
The Khayelitsha MSF clinic now has
81 children and more than 900 adults on
ARV drugs.
The Western Cape's PMTCT roll-out
began 3 years ago when public sector
highly active antiretroviral therapy
(HAART) was contrary to central
government policy. Several state doctors
across the country were victimised for
prescribing ARV drugs.
According to the province's Health
MEC, Piet Meyer, the reduced mother-
to-child infection rate was pivotal to his
department's agreeing to next year's
take-over of the 'One to One' private
funding of the Groote Schuur Hospital
(GSH) and Victoria Hospital's paediatric
AIDS unit.
'One to One' is a United Kingdom-
based NGO that has developed a
holistic child treatment model that
combines income generation and
education for families with treatment
and adherence. It has committed an
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additional R2.5 million, and the
province will pick up the tab for ARV
drugs and laboratory tests from 1 April
next year.
According to both Goemaere and
Paul Roux, head of the GSH paediatric
clinic, the province's public/private
financial partnerships are setting the
national benchmark. Roux said the
ARVs stood to prolong children's lives
by a dozen or more years, citing ARV
results in the USA where children who
were expected to die in 1992 are now
healthy teenagers leading near-normal
lives.
The GSH clinic, together with Victoria
Hospital, treats 220 children and 60
mothers, plus facilitates a steady stream
of income for the mothers by marketing
and distributing overseas their highly
sought-after beadwork. Roux labelled it
a 'unique holistic' model.
'The mothers used to come to our
clinic once a week because their kids
were sick. Now they come once a week
to deliver their beadwork for which
they get paid about R120 — and they
only need to bring their kids in on
average about once every 3 months'.
He said the women had generated
R500 000 from their beadwork in the 20
months since the project began.
Children in the GSH ward were
divided into two 'classes' measured by
hospitalisation: those who came in too
late to prevent chronic lung disease and
required continued hospitalisation, and
those who were put on ARV drugs 'in
time' to prevent lung damage.
A GSH study in October last year
showed that ART halved both the
hospitalisation rates and the length of
stay, thus freeing up vitally needed
beds.
Roux spends hours of his free time in
his garage making the wooden looms
upon which the mothers weave their
intricate beadwork.
The TAC's Nathan Geffen said: 'We're
dealing with a failure of political will
here. There doesn't seem to be any
rational self-interest in this debate with
government'.
He said the pharmaceutical industry
'at least has a rational self-interest and
makes compromises, but with the
government it's a battle between science
and irrationality'. 
Professor Craig Househam, Director
General of Health in the Western Cape,
said that health officials from the
Eastern Cape and the Orange Free State
had visited the local ARV sites to garner
experience and knowledge.  He was
unaware of other provinces having
done so.
South African-born Dr David
Altschuler, co-founder and chairman of
'One to One', said the programme
would shortly be expanded to the
Eastern Cape, where a recent tour he
made of labour, maternity and
paediatric wards revealed 'an
HIV/AIDS battlefield'. At the Dora
Nginza Hospital outside Port Elizabeth,
AIDS babies were dying at the rate of
three per day.
Goemaere said what made the
Western Cape so successful was having
engaged with private partners early on
and creating first a joint PMTCT task
team and then a joint ARV task team.
‘We certainly are not the only province
moving, but we are far ahead,' he said.
'It seems that other provinces lack
cohesive action and a dedicated AIDS
referral network’.
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